Project Number 3R01AG052510-04S1 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Escitalopram for Agitation in Alzheimer Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 10. Clinical Therapy Development for the Neuropsychiatric Symptoms of Dementia a. Pharmacological Researcher and Organization Principal Investigator LYKETSOS, CONSTANTINE G Principal Investigator First Name CONSTANTINE Principal Investigator Last Name LYKETSOS Awardee Organization JOHNS HOPKINS UNIVERSITY Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PA-13-302: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $332,357 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Escitalopram for Agitation in Alzheimer's Disease
